We are live on
!
Find out more
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
98% less funds holding
Funds holding: 546 → 12 (-534)
98% less capital invested
Capital invested by funds: $338M → $5.25M (-$333M)
100% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 529
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JCI
Jet Capital Investors
New York
|
+$2.15M |
| 2 |
TNB
Thomasville National Bank
Thomasville,
Georgia
|
+$146K |
